Symbols / LSTA $3.42 +7.55% Lisata Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
LSTA Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 30.89M Enterprise Value 14.68M Income -16.59M Sales 170.00K Book/sh 1.68 Cash/sh 1.77
Dividend Yield Payout 0.00% Employees 21 IPO P/E Forward P/E -5.18
PEG 118.40 P/S 181.71 P/B 2.03 P/C EV/EBITDA -0.81 EV/Sales 86.36
Quick Ratio 5.42 Current Ratio 5.76 Debt/Eq LT Debt/Eq EPS (ttm) -1.91 EPS next Y -0.66
EPS Growth Revenue Growth -90.00% Earnings 2026-05-07 ROA -43.15% ROE -75.53% ROIC
Gross Margin 100.00% Oper. Margin -30.79% Profit Margin 0.00% Shs Outstand 9.03M Shs Float 7.28M Short Float 0.22%
Short Ratio 0.35 Short Interest 52W High 5.07 52W Low 1.81 Beta 1.11 Avg Volume 103.07K
Volume 77.72K Target Price $9.50 Recom None Prev Close $3.18 Price $3.42 Change 7.55%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-21.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest LSTA news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-09 KLOSK STEVEN MARK Director 30,456 $0.00 $0
2026-01-09 AZAB MOHAMMAD Director 30,456 $0.00 $0
2026-01-09 HENSON HEIDI Director 30,456 $0.00 $0
2026-01-09 BROWN GREGORY B Director 30,456 $0.00 $0
2026-01-09 MAZZO DAVID J Officer and Director 81,000 $0.00 $0
2026-01-09 FLOWERS CYNTHIA LOUISE Director 30,456 $0.00 $0
2026-01-09 BUCK KRISTEN K Officer 25,000 $0.00 $0
2026-01-09 NISCO JAMES Officer 15,000 $0.00 $0
2026-01-09 IMAM TARIQ General Counsel 15,000 $0.00 $0
2025-01-08 KLOSK STEVEN MARK Director 15,789 $0.00 $0
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category